Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Copeland

Showing results (561-570 of 573) with videos related to

Pageof 58
Sort By:
Bioorganic & Medicinal Chemistry Letters|October 7, 2011
Synthesis and in vivo evaluation of cyclic diaminopropane BACE-1 inhibitorsLorin A Thompson, Jianliang Shi, Carl P Decicco, et al.
Science (New York, N.Y.)|June 5, 1999
Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteinsM D Tortorella, T C Burn, M A Pratta, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization productsJ V Duncia, J B Santella, C A Higley, et al.
Journal of Medicinal Chemistry|July 27, 2001
Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivoC B Xue, M E Voss, D J Nelson, et al.
Journal of Medicinal Chemistry|September 20, 2008
Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinaseDirk A Heerding, Nelson Rhodes, Jack D Leber, et al.
Archives of Biochemistry and Biophysics|February 8, 2003
Comparative studies of active site-ligand interactions among various recombinant constructs of human beta-amyloid precursor protein cleaving enzymeLisa M Kopcho, Jianhong Ma, Jovita Marcinkeviciene, et al.
Plos One|June 2, 2018
Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferationMichael J Thomenius, Jennifer Totman, Darren Harvey, et al.
Nature Chemical Biology|April 28, 2015
A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL modelsElayne Chan-Penebre, Kristy G Kuplast, Christina R Majer, et al.
Journal of Medicinal Chemistry|August 30, 2007
Novel ATP-competitive kinesin spindle protein inhibitorsCynthia A Parrish, Nicholas D Adams, Kurt R Auger, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2010
Antitumor activity of an allosteric inhibitor of centromere-associated protein-EKenneth W Wood, Latesh Lad, Lusong Luo, et al.
Pageof 58

Showing results (561-570 of 573) with videos related to

Sort By:
Pageof 58
Bioorganic & Medicinal Chemistry Letters|October 7, 2011
Synthesis and in vivo evaluation of cyclic diaminopropane BACE-1 inhibitorsLorin A Thompson, Jianliang Shi, Carl P Decicco, et al.
Science (New York, N.Y.)|June 5, 1999
Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteinsM D Tortorella, T C Burn, M A Pratta, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization productsJ V Duncia, J B Santella, C A Higley, et al.
Journal of Medicinal Chemistry|July 27, 2001
Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivoC B Xue, M E Voss, D J Nelson, et al.
Journal of Medicinal Chemistry|September 20, 2008
Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinaseDirk A Heerding, Nelson Rhodes, Jack D Leber, et al.
Archives of Biochemistry and Biophysics|February 8, 2003
Comparative studies of active site-ligand interactions among various recombinant constructs of human beta-amyloid precursor protein cleaving enzymeLisa M Kopcho, Jianhong Ma, Jovita Marcinkeviciene, et al.
Plos One|June 2, 2018
Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferationMichael J Thomenius, Jennifer Totman, Darren Harvey, et al.
Nature Chemical Biology|April 28, 2015
A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL modelsElayne Chan-Penebre, Kristy G Kuplast, Christina R Majer, et al.
Journal of Medicinal Chemistry|August 30, 2007
Novel ATP-competitive kinesin spindle protein inhibitorsCynthia A Parrish, Nicholas D Adams, Kurt R Auger, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2010
Antitumor activity of an allosteric inhibitor of centromere-associated protein-EKenneth W Wood, Latesh Lad, Lusong Luo, et al.
Pageof 58